“European evidence-based guidelines on tDCS noted probable efficacy across several indications, including depression and reducing pathological craving.”
Why it matterstDCS is a recognized platform for modern neuromodulation.
Science
Libo.Science is built on transcranial direct current stimulation — a method studied for more than 25 years and recognized in international clinical guidelines.
Scale of the problem
Clinical research shows it affects tens of millions of people worldwide — and remains one of the most frequent topics across many medical specialties.
Technology
tDCS — transcranial direct current stimulation — is a gentle, non-invasive neuromodulation technology studied for more than 25 years and actively used in Europe and the US.
stimulation sessions reviewed in an international safety analysis
No serious adverse events at standard parameters. Unlike pharmacological approaches, tDCS does not create dependence, does not interact with other medications, and does not require a prescription.
International recognition
Thousands of scientific papers on tDCS have been published in neuroscience, psychology, and medicine. Leading evidence-based guidelines worldwide address the method.
Canadian clinical guidelines for treating depression — among the most cited in psychiatry.
The UK’s National Institute for Health and Care Excellence.
Evidence-based recommendations on neuromodulation in clinical practice.
Neuroscience of libido
Modern neuroscience shows that sexual desire depends on brain systems for motivation, reward, and emotional regulation. Those are exactly what tDCS supports.
When these systems are overloaded or suppressed, desire drops — even with normal bloodwork and good general health.
Study results
Using tDCS to support sexual desire is a promising direction. Participants had marked libido decline.
Hurlbert Index of Sexual Desire. ~70 participants.
After 10 tDCS sessions, participants on average moved from low sexual desire to the upper end of average — on an international test.
The measure was the Hurlbert Index of Sexual Desire — a recognized tool in clinical sexology.
Evidence base
Key findings from the global research community on tDCS and sexual desire.
“European evidence-based guidelines on tDCS noted probable efficacy across several indications, including depression and reducing pathological craving.”
“A major evidence-based safety review of tDCS found no serious adverse events at standard protocols.”
“tDCS can produce measurable changes in cortical excitability, neurochemistry, and the functional connectivity of brain networks.”
“In a PET study, prefrontal tDCS was linked to increased extracellular dopamine in a motivation-and-reward region.”
“In women with reduced sexual desire, tDCS was associated with significant improvement versus control.”
Pre-order
Place a pre-order — shipping in July 2026.